IFNB1 and neoplasm: The continuous secretion of IFN-β by engineered mesenchymal stem cells in brain tumors derived from co-implanted tumor cells also resulted in slightly decreased macrophage numbers in tumors and increased frequency of microglia, especially activated microglia expressing major histocompatibility complex class II (MHC-II) (91).